Literature DB >> 9334327

The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.

T P Cujec1, H Okamoto, K Fujinaga, J Meyer, H Chamberlin, D O Morgan, B M Peterlin.   

Abstract

The human immunodeficiency virus encodes the transcriptional transactivator Tat, which binds to the transactivation response (TAR) RNA stem-loop in the viral long terminal repeat (LTR) and increases rates of elongation rather than initiation of transcription by RNA polymerase II (Pol II). In this study, we demonstrate that Tat binds directly to the cyclin-dependent kinase 7 (CDK7), which leads to productive interactions between Tat and the CDK-activating kinase (CAK) complex and between Tat and TFIIH. Tat activates the phosphorylation of the carboxy-terminal domain (CTD) of Pol II by CAK in vitro. The ability of CAK to phosphorylate the CTD can be inhibited specifically by a CDK7 pseudosubstrate peptide that also inhibits transcriptional activation by Tat in vitro and in vivo. We conclude that the phosphorylation of the CTD by CAK is essential for Tat transactivation. Our data identify a cellular protein that interacts with the activation domain of Tat, demonstrate that this interaction is critical for the function of Tat, and provide a mechanism by which Tat increases the processivity of Pol II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334327      PMCID: PMC316603          DOI: 10.1101/gad.11.20.2645

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  83 in total

1.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 2.  The role of multisite phosphorylation in the regulation of RNA polymerase II activity.

Authors:  M E Dahmus
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

3.  Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.

Authors:  T O'Brien; S Hardin; A Greenleaf; J T Lis
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

4.  The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor.

Authors:  R Roy; J P Adamczewski; T Seroz; W Vermeulen; J P Tassan; L Schaeffer; E A Nigg; J H Hoeijmakers; J M Egly
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

Review 5.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators.

Authors:  C M Chiang; R G Roeder
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

7.  A cyclin associated with the CDK-activating kinase MO15.

Authors:  T P Mäkelä; J P Tassan; E A Nigg; S Frutiger; G J Hughes; R A Weinberg
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

8.  A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.

Authors:  R P Fisher; D O Morgan
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

9.  Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK.

Authors:  W J Feaver; J Q Svejstrup; N L Henry; R D Kornberg
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

10.  Human immunodeficiency virus type 1 tat directs transcription through attenuation sites within the mouse c-myc gene.

Authors:  S Wright; X Lu; B M Peterlin
Journal:  J Mol Biol       Date:  1994-11-04       Impact factor: 5.469

View more
  90 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.

Authors:  F Demarchi; M I Gutierrez; M Giacca
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 3.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Transcriptional activation by artificial recruitment in mammalian cells.

Authors:  J Nevado; L Gaudreau; M Adam; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs.

Authors:  A M Trubetskoy; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.

Authors:  K Ellwood; W Huang; R Johnson; M Carey
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 7.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

8.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 10.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.